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Abstract
Introduction  and  Objectives:  Recent  updates  on  Pulmonary  Rehabilitation  highlight  the  impor-
tance of  patients’  self-efficacy  on  long-term  adherence  to  health-enhancing  behaviors.  The
Pulmonary  Rehabilitation  Adapted  Index  of  Self-Efficacy  (PRAISE)  is  an  adaptation  of  the  Gen-
eral Self-Efficacy  Scale.  This  study  aimed  to  translate,  culturally  adapt  and  evaluate  reliability
and validity  of  PRAISE  in  Portuguese  respiratory  patients.
Patients  or  Materials  and  Methods:  Forward-backward  translation  and  pilot  testing  were  per-
formed. Content  validity  was  assessed  by  a  multidisciplinary  panel  of  expert  judges.  To  evaluate
reliability and  validity,  150  respiratory  outpatients  on  Pulmonary  Rehabilitation  participated  in
a cross-sectional  study.  Descriptive  and  reliability  analyses,  and  exploratory  factorial  analysis
using principal  axis  factoring,  followed  by  oblique  oblimin  factor  rotation  were  conducted  to
identify construct  validity.  IBM® SPSS® version  22  was  used  to  perform  statistical  analysis.
Results:  150  patients  with  a  mean  age  of  67  years,  54%  male  and  83%  currently  on  Pulmonary
Rehabilitation  participated  in  the  study.  These  included  mainly  Chronic  Obstructive  Pulmonary
Disease patients  (46.7%)  but  also  Bronchiectasis  (20%),  Interstitial  Lung  Disease  (20%)  and  other
respiratory  diseases.  PRAISE  mean  score  was  49.  Exploratory  factor  analysis  extraction  provided
a 4-factor  solution  that  cumulatively  explained  52.3%  of  total  variance  (F1:  26.6%;  F2:  9.7%;
F3: 8.7%;  F4:  7.3%).  Portuguese  PRAISE  showed  a  reliability  of  0.78  (Chronbach  alpha).
Conclusions:  The  Portuguese  version  of  PRAISE  showed  adequate  psychometric  properties  for
it to  be  used  as  an  instrument  to  measure  self-efficacy  as  a  patient-centered  outcome  on
Pulmonary  Rehabilitation.sa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.U.  This  is  an
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ntroduction
ulmonary  Rehabilitation  is  widely  recognized  as  an  essen-
ial  component  in  the  integrated  care  of  patients  with
hronic  respiratory  disease.1 The  impact  of  this  compre-
ensive  intervention  can  be  assessed  by  patient-centered
utcomes,  mostly  performance-based,  and  to  a  certain
xtent  influenced  by  patients’  perceived  efficacy.2
Self-efficacy  was  defined  by  Albert  Bandura  as  a  per-
onal  construct  of  how  successfully  one  can  execute  a
equired  behavior  to  produce  a  desired  outcome.3 Accord-
ng  to  ‘‘Self-efficacy  as  a  unifying  theory  of  behavioral
hange’’,  expectations  of  personal  efficacy  are  based  on
our  sources  of  information:  performance  accomplishments
personal  mastery  experience),  vicarious  experience  (social
bservation),  verbal  persuasion  (suggestion)  and  physio-
ogical  states  (emotional  arousal  and  behavioral  control).3
ersonal  mastery  is  the  most  powerful  factor  since  it  enables
elf-perception  of  the  capacity  to  perform  a  task.4 Although
he  construct  of  self-efficacy  was  originally  related  to  spe-
ific  situations,  recent  approaches  generalized  the  concept
uggesting  that  general  self-efficacy  represents  the  confi-
ence  in  one’s  ability  to  deal  with  different  demanding
ituations.5 Self-efficacy  is  a  key  concept  in  many  behav-
or  change  frameworks  such  as  the  Self-efficacy  Theory,  the
ranstheoretical  Model,  the  Self-determination  Theory,  the
heory  of  Planned  Behavior,  and  the  Health  Belief  Model.6
Higher  sense  of  self-efficacy  has  been  found  to  be
ositively  associated  with:  better  outcomes  on  mobility,
ctivities  of  daily  living,  depression  and  quality  of  life  in
troke  patients7;  higher  levels  of  self-care  in  young  adults
ith  type  1  diabetes8;  better  attendance  and  improvements
n  Pulmonary  Rehabilitation9;  and  reduction  in  sedentary
ime  following  Pulmonary  Rehabilitation  in  people  with
hronic  Obstructive  Pulmonary  Disease.10
To  address  adaptive  behavior  change,  Pulmonary  Reha-
ilitation  enhances  self-efficacy  through  self-management
nterventions,  developing  skills  in  goal  setting,  prob-
em  solving,  decision-making,  and  taking  action  in  a
redefined  action  plan.1,11 Recent  updates  highlight  the
mportance  of  patient’s  self-efficacy  on  long-term  adher-
nce  to  health-enhancing  behaviors.1 Evidence  by  research
s  that  self-efficacy  baseline  assessment  proved  to  be  useful
or  predicting  positive  outcomes8 or  directing  the  interven-
ion  to  patient  specific  needs,9 maximizing  the  full  benefits
f  Pulmonary  Rehabilitation.
In  respiratory  clinical  practice,  self-efficacy  has  been
rstly  accessed  by  the  COPD  Self-Efficacy  Scale,  with
atients  rating  on  a  5-point  Likert  scale  the  amount  of
onfidence  in  managing  breathing  difficulties  in  34  diverse
ituations.12 This  scale  presents  a  five-factor  structure  (neg-
tive  effect,  intense  emotional  arousal,  physical  exertion,
eather/environmental,  and  behavioral  risk  factors)  and  a
ignificant  internal  consistency  (Cronbach’s  alpha  =  0.95),11
et  not  specific  to  the  Pulmonary  Rehabilitation  context.
or  this  purpose,  Vincent  and  co-authors  proposed  the
ulmonary  Rehabilitation  Adapted  Index  of  Self-Efficacy
PRAISE).2 The  PRAISE  tool  is  an  adaptation  of  the  Gen-Please  cite  this  article  in  press  as:  Santos  CD,  et  al.  Pulmonol.
ral  Self-Efficacy  Scale  (GSE)  by  Schwarzer  and  Jerusalem,5
dding  5  new  specific  items  to  the  previous  10.  Araújo  and
oura  have  already  validated  a  Portuguese  version  of  the
l
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SE,13 yet  the  assessment  of  such  a  construct  remains  to
e  explored  in  the  Portuguese  Pulmonary  Rehabilitation  set-
ing.
This  study  aimed  to:  1)  translate  and  culturally  adapt  the
RAISE  tool  into  European  Portuguese;  2)  evaluate  reliability
nd  construct  validity  of  PRAISE  in  Portuguese  respiratory
atients.
aterial and methods
he  validation  of  the  Portuguese  version  of  PRAISE  was
eveloped  in  two  phases:  1)  translation  and  cross-cultural
daptation  following  international  recommendations14 and
)  evaluation  of  reliability  and  validity  according  to  the
onsensus-based  Standards  for  the  selection  of  health  Mea-
urement  INstruments  (COSMIN)  guidelines.15,16
ranslation  and  cross-cultural  adaptation
ermission  to  translate  and  use  PRAISE  was  given  by  cor-
esponding  author  of  the  original  paper  describing  the
nstrument.2 As  GSE  has  been  validated  in  Portuguese,13 per-
ission  from  authors  was  obtained  to  integrate  the  already
ranslated  answer  key  and  10  items  into  the  forthcoming
RAISE  translation.  Subsequently,  the  process  proceeded  in
 steps:  1)  the  original  5  items  from  PRAISE  were  trans-
ated  by  2  independent  Portuguese  translators  (professional
ertified  translator  and  a  physiotherapist  living  in  an  English-
peaking  country  for  more  than  5  years);  2)  a  synthesis
ersion  was  proposed  by  an  independent  bilingual  transla-
or  (psychologist  and  certified  translator);  3)  blind  backward
ranslation  by  2  independent  bilingual  and  bicultural  trans-
ators,  living  in  an  English-speaking  country  for  more  than
 years  (medical  doctor  and  an  audit  executive  director);
)  Final  synthesis  by  a  multidisciplinary  committee  (previ-
us  5  independent  translators  and  also  this  study’s  main
esearcher,  a  pulmonologist  expert  in  Pulmonary  Rehabili-
ation,  and  the  author  of  the  original  instrument);  and  5)  a
ognitive  debriefing  was  performed  by  testing  and  re-testing
n  a sample  of  10  respiratory  patients  attending  Pulmonary
ehabilitation.
eliability  and  validity
o  evaluate  temporal  reliability,  a  test-retest  of  PRAISE
average  of  8-day  interval)  was  given  to  10  respiratory
utpatients  on  Pulmonary  Rehabilitation  at  Hospital  Pulido
alente  in  Lisbon,  Portugal.  Participants  were  diagnosed
ith  diverse  pathologies  (Chronic  Obstructive  Pulmonary
isease  n  =  2,  Asthma  n =  2,  Interstitial  Lung  Disease  n  =  2,
ronchiectasis  n  =  2  and  Lung  Cancer  n  =  2).
Construct  validity  included  factorial  analysis  and  internal
onsistency,  in  a cross-sectional  study  with  a  convenience
ample  of  150  respiratory  outpatients  on  Pulmonary  Rehabil-
tation  at  Hospital  Pulido  Valente  in  Lisbon,  Portugal.  Sample
ize  was  calculated  considering  the  recommendation  of  at 2019.  https://doi.org/10.1016/j.pulmoe.2019.06.003
east  10  subjects  per  item  of  the  instrument  scale.14 All
ubjects  gave  written  informed  consent  and  answered  the
ortuguese  PRAISE  tool  administered  by  a  physiotherapist.
tudy  conduction  was  approved  by  the  Ethics  Committee  of
ARTICLE IN PRESS+ModelPULMOE-1388; No. of Pages 6
Pulmonary  rehabilitation  adapted  index  of  self-efficacy  (PRAISE)  validated  to  Portuguese  respiratory  patients  3
Table  1  Portuguese  version  of  PRAISE  inter-item  correlations.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15
1  1.00  0.34**  0.29**  0.19*  0.32**  0.24**  0.13  0.30**  0.07  0.07  0.24**  0.12  0.24**  0.30**  0.09
2 1.00  0.30**  0.22**  0.32**  0.24**  0.07  0.30**  0.02  0.20**  0.30  0.13  0.21**  0.28**  0.12
3 1.00  0.25**  0.31**  0.37**  0.13  0.23**  0.20**  0.20**  0.17*  0.15*  0.16*  0.38**  0.26**
4 1.00  0.31**  0.32**  0.18**  0.33**  0.09  0.14*  0.07  0.23**  0.11  0.27**  0.28**
5 1.00  0.44**  0.11  0.21**  0.11  0.39**  0.28**  0.17*  0.23**  0.29**  0.25**
6 1.00  0.13  0.30**  0.07  0.30**  0.44**  0.12  0.32**  0.29**  0.23**
7 1.00  0.24**  0.04  0.14*  0.03  0.13  0.12  0.01  0.17*
8 1.00  0.03  0.10  0.27**  0.06  0.26**  0.27**  0.17*
9 1.00  0.11  0.02  0.03  0.03  0.05  0.21**
10 1.00  0.31**  0.03  0.35**  0.35**  0.28**
11 1.00  0.07  0.44**  0.26**  0.20**
12 1.00  0.12  0.20**  0.16*
13 1.00  0.19*  0.20**
14 1.00  0.19*
15 1.00
Note: *p < .05; **p < .01.
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Centro  Hospitalar  Universitário  Lisboa  Norte,  EPE  and  Cen-
tro  Académico  de  Medicina  de  Lisboa  (number  46/17),  and
trial  registered  as  NCT03875599  at  clinicaltrials.gov.
Statistical  analyses  included  preliminary  descriptive  and
reliability  analyses  of  the  PRAISE,  including  item  means,
corrected  item-scale  correlations,  scale  means  and  vari-
ances,  and  alpha  reliability  coefficients.  Construct  validity
was  examined  through  Exploratory  Factorial  Analysis.  (EFA).
The  Kaiser--Meyer--Olkin  (KMO)  measures  of  sampling  ade-
quacy,  and  Bartlett’s  test  of  sphericity  were  used  to  assess
the  suitability  of  the  data  for  factor  analysis.17 Principal  Axis
Factoring  was  used  to  perform  EFA,  usually  considered  more
accurate  since  it  estimates  common  variance  and  consid-
ers  error  variance.18,19 The  Eigenvalue  (greater  than  1),  the
cumulative  percent  of  variance  explained,  and  the  number
and  magnitude  of  the  factor  loadings  determined  the  num-
ber  of  factors  to  be  retained.  Factor  rotation  was  conducted
to  maximize  interpretability  and,  because  some  correlations
among  factors  were  expected,  an  oblique  oblimin  factor
rotation  method  was  applied.18,19 All  analyses  were  con-
ducted  in  IBM® SPSS® version  22.
Results
Instrument
The  PRAISE  tool  developed  by  Vincent2 is  composed  of  a
total  of  15  items,  combining  10  items  from  Schwarzer  and
Jerusalem  GSE  scale5 and  5  new  specific  items  related  to  a
Pulmonary  Rehabilitation  program.  Each  item  is  scored  from
1  to  4  with  a  total  range  from  15  to  60,  with  higher  scores
indicating  higher  levels  of  self-efficacy.  Items  4,  7,  9,  12  and
15  are  specific  to  Pulmonary  Rehabilitation  as  proposed  byPlease  cite  this  article  in  press  as:  Santos  CD,  et  al.  Pulmonol.
the  original  authors  of  PRAISE.2 The  remaining  items  are  in
accordance  with  the  Portuguese  GSE  by  Araújo  and  Moura.13
The  Portuguese  tool  version  for  clinical  practice  is  provided
in  appendix  1,  with  permission  from  PRAISE  original  authors.
r
t
s
e
articipants
he  150  participants  had  a mean  age  of  67  ±  1.7  years  and
4%  were  male.  Conditions  indicated  for  Pulmonary  Rehabil-
tation  were  Chronic  Obstructive  Pulmonary  Disease  (46.7%),
ronchiectasis  (13.3%),  Interstitial  Lung  Disease  (13.3%),
sthma  (8.7%),  Lung  Cancer  Surgery  (8.0%)  and  other  res-
iratory  conditions  (15%).  All  participants  were  Pulmonary
ehabilitation  outpatients,  83%  currently  in  a  program  and
7%  being  followed-up.  PRAISE  mean  score  and  standard
eviation  were  49  ±  0.5,  with  a  median  of  50  and  range
alues  of  32  minimum  and  60  maximum.
eliability
he  relationship  between  the  two  testing  periods  showed
ome  temporal  consistency  for  PRAISE,  whether  measured
y  Pearson  correlation  coefficient  (0.71)  or  by  Intraclass
orrelation  Coefficient  (0.76).
For  the  total  of  the  150  participants  the  inter-items  cor-
elations  were  relatively  low,  specifically  for  the  items  7,
 and  12  (Table  1).  Cronbach’s  coefficient  was  0.78  and
ncreased  if  items  9  and  12  were  omitted  from  the  scale
Table  2).  The  split-half  coefficient  was  0.73  and  analysis
howed  no  significant  differences  between  the  scores  of  the
wo  parts  of  the  questionnaire.
alidity
efore  conducting  the  EFA,  the  Bartlett  sphericity  test  and
he  KMO  test  were  performed.  Factor  analysis  seemed  to
e  adjusted  to  PRAISE  scores  as  Bartlett’s  test  of  sphericity 2019.  https://doi.org/10.1016/j.pulmoe.2019.06.003
eached  statistical  significance  (2 =  296.582,  p  =  0.000)  and
he  KMO  a  value  of  0.80.  After  EFA  extraction  the  provided
olution  considered  4  factors  that  accounted  for  a  total  of
xplained  variance  of  52.3%  (Table  3).
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Table  2  Portuguese  version  of  PRAISE  item  total  statistics.
Mean  Standard
deviation
Scale  variance  if
item  Deleted
Corrected
item-total
correlation
Cronbach’s  alpha
if item  deleted
1  3.27  0.77  30.02  0.39  0.77
2 3.15  0.70  30.08  0.43  0.77
3 3.31  0.78  29.14  0.49  0.76
4 3.00  0.91  28.55  0.40  0.78
5 3.35  0.73  27.83  0.55  0.76
6 3.37  0.68  28.97  0.56  0.76
7 3.15  0.88  32.14  0.23  0.78
8 3.29  0.72  30.21  0.43  0.77
9 3.39  0.73  32.54  0.09  0.80
10 3.11  0.76  29.09  0.42  0.77
11 2.97  1.02  30.12  0.41  0.77
12 3.64  0.56  31.66  0.19  0.79
13 3.47  0.75  30.26  0.38  0.77
14 3.33  0.77  29.28  0.49  0.77
15 3.27  0.79  29.79  0.40  0.77
Table  3  Exploratory  factorial  analysis  (Principal  Axis  Fac-
toring with  oblimin  rotation).
Items  Factor  1 Factor  2 Factor  3 Factor  4
1  0.61
2 0.66
3 0.62
5 0.57
6 0.43
11  0.52
13  0.77
10  0.69
12 0.74
4 0.47
7 0.52
15 0.90
8 0.74
9 0.44
14 0.56
Eigenvalue  3.99  1.45  1.31  1.10
Percentage  of
variance
explained  by
each  factor
26.59  9.67  8.72  7.34
Percentage  of
variance
explained  by
52.34
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Table  4  Correlations  between  factors  of  the  Portuguese
version  of  PRAISE.
Factor  1  Factor  2  Factor  3  Factor  4
Factor  1  1
Factor  2  0.29  1
Factor  3  0.54  0.33  1
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Factor  1  contributed  with  26.6%  of  the  explained  variance
ombining  7  items  from  the  original  GSE.  Factor  2  explained
he  variance  in  9.7%  and  included  2  items  from  each  scale.
actor  3  accounted  for  8.7%  of  explained  variance  with  3
pecific  items  from  PRAISE.  The  final  factor  contributed  withPlease  cite  this  article  in  press  as:  Santos  CD,  et  al.  Pulmonol.
.3%  of  variance  and  included  2  items  of  GSE  and  1  item  of
RAISE.  In  this  four-factor  solution,  items  4  and  7  did  not  fit
s  well  statistically  as  other  items;  these  items  appeared  to
v
i
Factor  4  0.21  0.18  0.11  1
PRAISE total  score  0.89  0.67  0.64  0.64
e  cross-loaded  given  that  both  presented  loadings  on  other
actors  did  not  differ  more  than  0.2.  In  addition,  items  4,
 and  9  presented  the  smaller  loaded  values  in  the  respec-
ive  factors  extracted.  The  correlation  coefficient  between
actors  was  significant  as  shown  on  Table  4.
iscussion
his  study  presents  a  Portuguese  version  of  the  PRAISE  tool
s  a  result  of  translation  and  cross-cultural  adaptation  by
n  expert  committee,  including  the  original  author  of  the
nstrument,  in  accordance  with  international  recommen-
ations.  Authors  provide  the  Portuguese  Version  of  PRAISE
n  appendix  to  enable  all  Portuguese  speaking  countries  to
easure  self-efficacy  as  a  patient-centered  outcome  of  Pul-
onary  Rehabilitation.
As PRAISE  measures  self-efficacy  enabling  the  clinician
o  identify  important  determinants  of  successful  behav-
or  change,1,2 authors  applied  such  an  instrument  to  the
iversity  of  respiratory  patients  on  Pulmonary  Rehabilita-
ion.  Such  heterogeneity  may  have  contributed  to  different
esting  results  compared  with  the  original  PRAISE  study
pplied  exclusively  to  Chronic  Obstructive  Pulmonary  Dis- 2019.  https://doi.org/10.1016/j.pulmoe.2019.06.003
In  this  study,  the  reliability  estimated  for  the  Portuguese
ersion  of  PRAISE  was  0.78,  slightly  lower  than  the  one  found
n  the  original  version  of  the  scale,  0.95.2 Although  one
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Pulmonary  rehabilitation  adapted  index  of  self-efficacy  (PRA
study  has  shown  this  to  be  a  two-dimensional  scale,20 in  the
present  study  four  different  factors  were  found,  suggesting
discriminative  self-efficacy  qualities.
The  first  factor  included  seven  items  from  the  GSE  related
with  overall  self-efficacy  explaining  26.6%  of  variance.  The
second  factor,  explaining  9.7%  of  variance,  included  two
items,  one  from  each  scale,  regarding  individuals’  belief
about  their  own  capacities.  The  third  factor  included  three
specific  items  from  PRAISE,  all  describing  performance
accomplishment,  explaining  8.7%  of  variance.  Finally,  the
fourth  factor  included  two  items  of  GSE  and  one  PRAISE
item,  together  focus  on  rationale  for  coping,  as  either  a  trait
or  strategy,  explaining  7.3%  of  variance.
Overall,  the  Portuguese  PRAISE  version  explained  52.3%
of  the  variance.  While  EFA  solutions  that  account  for
60%  of  the  total  variance  can  be  considered  satisfac-
tory,  it  is  not  uncommon  to  achieve  inferior  values  for
multidimensional  constructs.18,19 In  fact,  in  this  perspec-
tive,  Bandura  elegantly  explained  how  expectations  of
personal  efficacy  are  dynamic  and  may  vary  in  magni-
tude,  generality  or  strength.3 The  results  also  indicate
that  some  items  may  not  be  contributing  significantly
to  the  measured  construct.  Nonetheless,  considering  that
the  overall  factor  structure  is  conceptually  plausible,  the
PRAISE  presents  itself  as  a  practical  and  scientifically  useful
instrument.
The  fact  that  it  was  a  convenience  sample  with  all
patients  attending  Pulmonary  Rehabilitation  at  the  same
center  may  be  a  study  limitation.  In  addition,  differences  in
the  rehabilitation  program  or  clinical  conditions  may  have
had  an  effect  on  how  the  individuals  perceived  their  self-
efficacy  in  regards  to  the  Pulmonary  Rehabilitation  program.
Hence,  future  studies  should  evaluate  the  reliability  and
validity  of  PRAISE  for  specific  patient  groups.
Given  the  lack  of  evidence  published  about  the  orig-
inal  PRAISE  factor  structure,2 these  findings  remain  to
be  compared  with  further  studies.  The  four-factor  struc-
ture  proposed  enables  future  studies  of  PRAISE  construct
convergent  validity,  by  a  cross-sectional  comparison  of
scores  of  other  Pulmonary  Rehabilitation  instruments  with
PRAISE  results,16,21 such  as  those  presented  by  Vincent2
and  Song.20 Furthermore,  continuing  research  on  longitudi-
nal  validity  may  increase  knowledge  on  clinically  important
self-efficacy  change  and  PRAISE  responsiveness.  In  fact,
some  studies  already  applied  PRAISE  on  a  home-based  Pul-
monary  Rehabilitation22 and  self-management  program,23
but  with  no  differences  when  compared  with  traditional
care.
Conclusions
The  Portuguese  version  of  PRAISE  showed  adequate  psycho-
metric  properties  with  a  reliability  of  0.78  alpha  Chronbach
and  a  validity  of  52.3%  of  explained  total  variance.  ThisPlease  cite  this  article  in  press  as:  Santos  CD,  et  al.  Pulmonol.
study  enables  Portuguese  clinicians  with  the  instrument  to
measure  self-efficacy  as  a  patient-centered  outcome  on
Pulmonary  Rehabilitation,  in  accordance  with  international
guidelines. PRESS
 validated  to  Portuguese  respiratory  patients  5
unding
his  work  was  supported  by  Fundação  para  a  Ciência  e  Tec-
ologia  (FCT)  and  Nippon  Gases  Portugal  under  the  PhD
tudentship  in  Industry  grant  PDE/BDE/127785/2016.
onflicts of interest
he  authors  have  no  conflicts  of  interest  to  declare.
uthor contributions
antos  C.  conceived,  planned  and  executed  the  study,  par-
icipated  in  the  multidisciplinary  panel  of  expert  judges,
nalyzed  and  interpreted  data,  and  wrote  and  revised  the
anuscript.  Santos  A.  analyzed  and  interpreted  data,  and
rote  and  revised  the  manuscript.  Santos  M.  interpreted
ata,  and  wrote  and  revised  the  manuscript.  Rodrigues  F.
articipated  in  the  multidisciplinary  panel  of  expert  judges
nd  revised  critically  the  final  version  of  the  manuscript  for
mportant  intellectual  content.  Bárbara  C.  revised  critically
he  final  version  of  the  manuscript  for  important  intellectual
ontent.  All  authors  have  read  and  approved  the  manuscript.
cknowledgements
uthors  are  grateful  to  Emma  Vincent,  José  Costa,  Fábio
erreira,  Liliana  Dias,  Patrícia  Monteiro  and  Mariana  Cerejo
or  their  collaboration  as  experts  on  the  translation  and
ross-cultural  adaptation  of  the  instrument.  Authors  also
hank  the  Pulmonary  Rehabilitation  Team  of  Hospital  Pulido
alente,  namely  Ana  Filipe,  Paula  Raposo,  Clara  Cruz,  Marta
antos,  Rute  Roberto,  Cláudia  Costa,  Susana  Garcia,  Marta
iguéns  and  Carla  Baptista,  for  the  opportunity  to  apply  the
nstrument  to  patients  on  treatment.
ppendix A. Supplementary data
upplementary  material  related  to  this  article  can  be  found,
n  the  online  version,  at  doi:https://doi.org/10.1016/
.pulmoe.2019.06.003.
eferences
1. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L,
Rochester C, et al. An official American Thoracic Soci-
ety/European Respiratory Society statement: key concepts
and advances in pulmonary rehabilitation. Am J Respir
Crit Care Med. 2013;188(8):e13--64, http://dx.doi.org/
10.1164/rccm.201309-1634ST.
2. Vincent E, Sewell L, Wagg K, Deacon S, Williams J,
Singh S. Measuring a change in self-efficacy following
pulmonary rehabilitation: an evaluation of the PRAISE 2019.  https://doi.org/10.1016/j.pulmoe.2019.06.003
tool. Chest. 2011;140(6):1534--9, http://dx.doi.org/10.1378/
chest.10-2649.
3. Bandura A. Self-efficacy: toward a unifying theory of behavioral
change. Psychol Rev. 1977;84(2):191--215.
 IN+ModelP
6
1
1
1
1
1
1
1
1
1
1
2
2
2
23. Mitchell KE, Johnson-Warrington V, Apps LD, Bankart J, Sewell L,
Williams JE, et al. A self-management programme for COPD: aARTICLEULMOE-1388; No. of Pages 6
 
4. Bandura A. Self-efficacy: the exercise of control. Basingstoke:
W. H. Freeman; 1997. p. 592.
5. Schwarzer RJM. Generalized Self-Efficacy Scale. In: Weinman
JWS, Johnston M, editors. Measures in health psychology: a
user’s portfolio Causal and control beliefs. Windsor: NFER-
NELSON; 1995. p. 35--7.
6. Downs DSNC, Hausenblas HA, Rauff EL. Why do people change
physical activity behaviour? In: Nigg RC, editor. ACSM’s Behav-
ioral aspects of physical activity and exercise: American College
of Sports Medicine. 2014. p. 1--38.
7. Korpershoek C, van der Bijl J, Hafsteinsdottir TB. Self-
efficacy and its influence on recovery of patients with
stroke: a systematic review. J Adv Nurs. 2011;67(9):1876--94,
http://dx.doi.org/10.1111/j.1365-2648.2011.05659.x.
8. Johnston-Brooks CH, Lewis MA, Garg S. Self-efficacy impacts
self-care and HbA1c in young adults with Type I diabetes. Psy-
chosom Med. 2002;64(1):43--51.
9. Selzler AM, Rodgers WM, Berry TR, Stickland MK. The
importance of exercise self-efficacy for clinical outcomes in
pulmonary rehabilitation. Rehabil Psychol. 2016;61(4):380--8,
http://dx.doi.org/10.1037/rep0000106.
0. Liacos A, McDonald CF, Mahal A, Hill CJ, Lee AL, Burge AT, et al.
The Pulmonary Rehabilitation Adapted Index of Self-Efficacy
(PRAISE) tool predicts reduction in sedentary time following
pulmonary rehabilitation in people with chronic obstructive
pulmonary disease (COPD). Physiotherapy. 2019;105(1):90--7,
http://dx.doi.org/10.1016/j.physio.2018.07.009.
1. Blackstock FC, Lareau SC, Nici L, ZuWallack R, Bourbeau
J, Buckley M, et al. Chronic Obstructive Pulmonary Disease
Education in Pulmonary Rehabilitation. An Official Ameri-
can Thoracic Society/Thoracic Society of Australia and New
Zealand/Canadian Thoracic Society/British Thoracic Society
Workshop Report. Ann Am Thorac Soc. 2018;15(7):769--84,
http://dx.doi.org/10.1513/AnnalsATS.201804-253WS.
2. Wigal JK, Creer TL, Kotses H. The COPD Self-Efficacy Scale.
Chest. 1991;99(5):1193--6.
3. Miguel Araújo OM. Estrutura factorial da General Self-
Efficacy Scale (Escala de Auto-Eficácia Geral) numa amostraPlease  cite  this  article  in  press  as:  Santos  CD,  et  al.  Pulmonol.
de professores portugueses. Laboratório de Psicologia.
2011;9(1):95--105.
4. Sousa VD, Rojjanasrirat W.  Translation, adaptation and val-
idation of instruments or scales for use in cross-cultural PRESS
C.D.  Santos  et  al.
health care research: a clear and user-friendly guideline.
J Eval Clin Pract. 2011;17(2):268--74, http://dx.doi.org/
10.1111/j.1365-2753.2010.01434.x.
5. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford
PW, Knol DL, et al. The COSMIN checklist for assess-
ing the methodological quality of studies on measurement
properties of health status measurement instruments: an
international Delphi study. Qual Life Res. 2010;19(4):539--49,
http://dx.doi.org/10.1007/s11136-010-9606-8.
6. Mokkink LB, Terwee CB, Patrick DL, Alonso J, Strat-
ford PW, Knol DL, et al. The COSMIN study reached
international consensus on taxonomy, terminology, and defi-
nitions of measurement properties for health-related patient-
reported outcomes. J Clin Epidemiol. 2010;63(7):737--45,
http://dx.doi.org/10.1016/j.jclinepi.2010.02.006.
7. DeVellis RF. Scale development: theory and applications. New-
bury Park: SAGE Publications; 1991.
8. GJ K. Exploratory factor analysis: theory and application.
Netherlands: Rijksuniversiteit Groningen; 2004.
9. Costello ABOJ. Best practices in Exploratory Factor Analysis:
four recommendations for getting the most from your analysis.
Pract Assess Res Eval. 2005;10(7):1--9.
0. Song HY, Nam KA. Psychometric properties of the Korean
version of the Pulmonary Rehabilitation Adapted Index
of Self-Efficacy (PRAISE) for individuals with COPD.
Int J Chron Obstruct Pulmon Dis. 2017;12:2611--20,
http://dx.doi.org/10.2147/COPD.S142488.
1. Finch EBD, Stratford P, Mayo N. Why measurement properties
are important. In: F E, editor. Physical Rehabilitation Out-
come Measures----a guide to enhanced clinical decision making.
Canada: Lippincott Williams & Wilkins; 2002. p. 26--41.
2. Holland AE, Mahal A, Hill CJ, Lee AL, Burge AT, Cox
NS, et al. Home-based rehabilitation for COPD using
minimal resources: a randomised, controlled equiva-
lence trial. Thorax. 2017;72(1):57--65, http://dx.doi.org/
10.1136/thoraxjnl-2016-208514. 2019.  https://doi.org/10.1016/j.pulmoe.2019.06.003
randomised controlled trial. Eur Respir J. 2014;44(6):1538--47,
http://dx.doi.org/10.1183/09031936.00047814.
